Gattefossé has achieved globally standardised and verified production of cosmetic ingredients at its United States manufacturing facility in Texas.
Five cosmetic ingredients have now achieved manufacturing equivalency at its Lufkin site, marking a major milestone in the company's strategy to expand regional manufacturing while ensuring consistent quality and reliable supply worldwide.
Building on EFfCI certification for personal care products, the Lufkin site now manufactures cosmetic ingredients according to the same quality, analytical and regulatory standards applied across Gattefossé's global production network.
Each validation is supported by a complete technical equivalence file, including analytical validation, stability data, and regulatory documentation to ensure seamless integration into customers’ development and commercialization programmes.
The five ingredients are:
Emulium Mellifera MB, a natural oil-in-water emulsifier that adapts to different skin types and environmental conditions while delivering outstanding sensory properties.
Compritol 888 CG MB, a multifunctional texturizing agent used as a consistency enhancer, oil-phase thickener and stabilizer in skincare, make-up and sun care formulations.
Emulium Delta MB, an oil-in-water emulsifier offering high formulation flexibility together with a soft, velvety feel.
Plurol Diisostearique CG, a water-in-oil emulsifier particularly suited to make-up and sun care formulations thanks to its minimalist composition and formulation versatility.
LAS MB, a versatile, non-ionic surfactant suitable for skin and hair care formulations, including creams, lotions, wipes and microemulsion systems.
"The validation of our first ingredients at our Lufkin facility is a major achievement for our portfolio,” said Ben Blinder, chief operating officer at Gattefossé USA.
“We are directly answering our partners' need for supply chain resilience and dependable domestic sourcing in an increasingly unpredictable global market,” he added.